Compare Mounjaro vs Wegovy: Which Suits You Better?
Mounjaro or Wegovy In Stock: UK Availability Breakdown
The question of whether to choose Mounjaro or Wegovy has become increasingly relevant as both treatments are now readily available in the UK. Unlike the supply shortages that affected Wegovy throughout 2023 and early 2024, EverydayMeds maintains consistent stock levels of all five Wegovy doses, from the 0.25mg starter dose through to the 2.4mg maintenance pen. This reliable availability means you can progress through the dose escalation schedule without interruption, which is crucial for optimal treatment outcomes.
For those considering Mounjaro or Wegovy specifically, the availability advantage extends beyond just having stock on the shelf. Our streamlined ordering process ensures that once your prescriber approves your treatment, you'll receive your medication within 24 hours via temperature-controlled delivery. This is particularly important for both treatments, as they require proper cold-chain storage to maintain their effectiveness as prescription-only medicines.
Wegovy Pricing and Value: Complete UK Cost Breakdown
When comparing Mounjaro or Wegovy costs, Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Our bundle options provide additional convenience, with the Intro Duo covering your first eight weeks for £169.99, combining both 0.25mg and 0.5mg doses in a single order.
The Consistency bundles offer practical value for those established on a specific dose, with two 0.25mg pens available for £139.99 or two 2.4mg maintenance pens for £419.99. For patients planning ahead, the Ultimate Stability Trio provides three months of 2.4mg maintenance treatment for £649.99, eliminating the need for monthly reorders. This pricing structure makes the Mounjaro or Wegovy decision partly dependent on your budget preferences and treatment timeline, though both represent significant investments in long-term weight management.
Clinical Evidence: How Mounjaro or Wegovy Compare in Trials
When evaluating Mounjaro or Wegovy through clinical evidence, both treatments have demonstrated significant efficacy in their respective trial programmes. Wegovy's STEP trials, particularly STEP 1 published by Wilding et al. in NEJM 2021, showed that patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major adverse cardiovascular events among participants with established cardiovascular disease.
Mounjaro's SURMOUNT trials have shown promising results with its dual GIP and GLP-1 receptor agonist mechanism, though direct head-to-head comparisons between Mounjaro or Wegovy remain limited due to different trial designs and patient populations. Both treatments require careful medical supervision and work best alongside a reduced-calorie diet and increased physical activity, making the choice between them a clinical decision rather than simply comparing trial percentages.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone called glucagon-like peptide-1. This hormone is normally released by your intestines after eating and signals to your brain that you're becoming full, helping to regulate appetite and food intake. When considering Mounjaro or Wegovy mechanisms, Wegovy's single-target approach focuses specifically on the GLP-1 pathway, which has been extensively studied for both diabetes management and weight control. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Additionally, Wegovy may help reduce food cravings by acting on appetite centres in the brain, making it easier to adhere to a calorie-controlled eating plan as part of your weight management programme.
Your Wegovy Ordering Process: Assessment to Delivery
The process for obtaining either option in the Mounjaro or Wegovy comparison begins with our 3-minute online clinical assessment, designed to evaluate your suitability for weight management treatment. Our prescribers, operating under GPhC registration #9012878, review your medical history, current medications, and weight management goals to determine the most appropriate treatment option. Standard prescriber review takes up to 3 working days, though express 24-hour review is available for urgent cases. Once approved, your Wegovy pens are dispatched via next-day delivery using our temperature-controlled cold-chain system, ensuring the medication remains effective throughout transit. The entire process from assessment to delivery typically takes 2-4 working days, significantly faster than traditional GP routes or specialist weight management clinics.
Storage and Practical Considerations: Wegovy vs Mounjaro
A key practical difference when choosing between Mounjaro or Wegovy relates to storage flexibility, where Wegovy offers a significant advantage. Once removed from refrigerated storage, Wegovy pens can be kept at room temperature (below 30°C) for up to 6 weeks, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy more suitable for patients who travel frequently or prefer not to refrigerate their medication continuously. Both treatments use pre-filled FlexTouch pens that require weekly injection, typically in the thigh, abdomen, or upper arm. The dose escalation schedule for Wegovy is fixed, starting at 0.25mg for four weeks, then increasing every four weeks until reaching the 2.4mg maintenance dose, ensuring your body gradually adapts to the treatment while minimising potential side effects.
Mounjaro or Wegovy: Supply Chain Reliability in the UK
The reliability of supply has become a crucial factor when patients consider Mounjaro or Wegovy options, particularly given the widespread shortages that affected diabetes and weight management medications throughout 2023. EverydayMeds has established direct relationships with Novo Nordisk to ensure consistent Wegovy availability across all doses, from starter pens through to maintenance treatment. Our inventory management system automatically tracks stock levels and reorder points, preventing the treatment interruptions that can compromise your weight management progress.
This supply reliability extends to our emergency reorder service, where patients approaching the end of their current dose can access expedited processing to avoid treatment gaps. Unlike some providers who may substitute unavailable doses or place patients on waiting lists, our commitment to maintaining Mounjaro or Wegovy availability means you can plan your treatment schedule with confidence. This is particularly important for Wegovy, where missing doses can require restarting the escalation schedule from a lower dose, potentially delaying your progress toward the therapeutic 2.4mg maintenance level.
Making Your Decision: Expert Support for Mounjaro or Wegovy
Choosing between Mounjaro or Wegovy ultimately depends on your individual medical profile, lifestyle requirements, and treatment preferences. Our clinical team provides personalised guidance during your assessment, considering factors such as your weight management history, any existing medical conditions, and your specific goals for treatment. Both medications are prescription-only medicines that require ongoing medical supervision, making the initial prescriber consultation crucial for long-term success. Complete your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your personalised weight management journey. Remember to use discount code FIRST40 for new customers or DOSE25 for returning patients, and take advantage of our next-day delivery service to start treatment without unnecessary delays. Whether you choose Mounjaro or Wegovy, our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medication with full clinical support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
